Kuick Research is a company committed to providing its customers with detailed research and consulting reports and in-depth market analyses in a cost-effective manner. The company’s reports are elaborated by highly-trained and experienced researchers and analysts. The research reports offered by Kuick Research provide vital qualitative and quantitative information, describe technical and market trends, present competitive benchmarking and customer insights.
The Company serves clients across numerous industries including healthcare, tourism, consumer goods, automotive, pharmaceuticals, retail, energy and power, and a far more. Kuick Research’s products portfolio is made of both ready-made and customized reports, containing industry insights, data collections, competitor tracking, business-to-business and business-to-customer surveys.
Publications found:
335
Sort by:
Global Cancer Stem Cell Therapy Market Outlook 2020
US$ 2,400.00
... Stem Cells Stem Cell Transplants Classification Cancer Stem Cell Therapy Mechanism of Action Global Cancer Stem Cell Market Analysis Global Cancer Stem Cell Clinical Pipeline by Company & Phase Global Cancer Stem Cell Clinical Pipeline: 32 Therapies Global Cancer Stem Cell Market ...
April 2016
132 pages
Global Dendritic Cell Cancer Vaccine Market Outlook 2020
US$ 1,800.00
... Dendritic Cells New Vaccine Strategies That Exploit Dendritic Cells Biochemistry Dendritic Cell Cancer Vaccine Market & Clinical Insight Comparative Insight of Dendritic Cell Vaccines & Other Class of Vaccines Dendritic Cell Cancer Vaccine Pipeline by Country, Company, Indication & Phase Dendritic Cell Cancer ...
March 2016
213 pages
Global Liquid Biopsy Market Opportunity & Technology Outlook 2020
US$ 1,800.00
... Liquid Biopsy Market Clinical Investigation Using Cell-Free Circulating Tumor DNA for Different Indications Combinational Analysis on the Working of Circulating Tumor Cells & Cell-Free Tumor DNA Market Share of Different Liquid Biopsy ...
March 2016
105 pages
Global T-Cell Lymphoma Market & Clinical Pipeline Insight
US$ 1,800.00
... Global T-Cell Lymphoma Market & Clinical Pipeline Insight” Report Highlight: Mechanism of T-Cell Lymphoma Therapeutics T-Cell Lymphoma Drug Market Overview T-Cell Lymphoma Drug Clinical Pipeline By Company & Phase T-Cell Lymphoma Drug Clinical Pipeline By Peripheral & Cutaneous T-cell Lymphoma T-Cell Lymphoma ...
March 2016
168 pages
US Biosimilars Market Opportunity & Clinical Pipeline Analysis
US$ 2,400.00
... Biosimilars Market Impact of Biosimilars in US Market Impact of Reimbursement Policies on US Biosimilars Market Zarxio: First Approved Biosimilar in US US Biosimilar Clinical Pipeline By Company, Indication & Phase US Biosimilar Clinical Pipeline: 104 Biosimilars Marketed Biosimilars: 1 Biosimilar ...
February 2016
330 pages
Global Peptide Cancer Vaccine Market & Clinical Pipeline Insight
US$ 1,500.00
... Peptide Cancer Vaccine Need of Peptide Cancer Vaccines Clinical Trials Efficacy Study of Synthetic Peptide Analog Obtained From WT1 Oncoprotein Wide Spectrum Action of Peptide Cancer Vaccines against Major Cancer Global Peptide Cancer Vaccine Pipeline: 41 Vaccines Global Peptide Cancer Vaccine ...
February 2016
142 pages
US Generic Drug Market Opportunity Outlook 2020
US$ 1,500.00
... Generic Drugs Supportive Features of US Generic Drug Laws Effect of Generic Drug Import on US Economy Methods to Achieve Higher Cost Arbitrage by Generic Drugs Role of Online Pharmacies in Expansion of US Generic Drugs Market US Generic Drugs Market ...
February 2016
100 pages
US Transdermal Patch Market & Clinical Trial Insight
US$ 3,600.00
... Transdermal Patch Market & Clinical Trial Insight” Report Highlights: US Transdermal Patch Market Overview Generic & Branded Transdermal Patches US Transdermal Patch Market: Value Chain Analysis US Transdermal Patch Contract Manufacturing Organization US Transdermal Patch ...
November 2015
300 pages
India Road & Highways Sector Opportunity Analysis
US$ 1,800.00
... Road & Highway Sector Overview & Network Analysis Planned & Under Construction Highway & Expressway Infrastructure Toll Collection Mechanism: Opportunities & Challenges India Road & Highway Sector Investment Scenario FDI Policy & Government Initiatives PPP in Roads & Highway Infrastructure Development Project ...
November 2015
150 pages
Europe Biosimilars Market Opportunity Outlook 2020
US$ 2,400.00
... European biosimilars market. “Europe Biosimilars Market Opportunity Outlook 2020” Report Highlight: Europe Biosimilars Market Outlook Europe Biosimilars Market Trend Analysis by Country Introduction of Biosimilars in European Market by Segment Clinical & Non Clinical Guidelines Europe Biosimilar ...
November 2015
310 pages
Global Cancer Vaccine Market & Clinical Trial Insight
US$ 4,000.00
... cancer vaccines will hit the shelf in coming years. “Global Cancer Vaccine Market & Clinical Trial Insight” Report Highlights: Global Cancer Market Overview Emergence of Personalized Cancer Vaccines Platforms for Cancer Vaccines Delivery Mechanism of Cancer Vaccines Global Cancer Vaccines Clinical ...
September 2015
750 pages
India Smart Cities Infrastructure Investment Outlook
US$ 1,500.00
... Smart City Core Components of Smart City Aspects of Smart City Infrastructure Smart Cities in India Key Trends in Smart City Development Government Support and Policy Outline India Smart Cities Infrastructure Guidelines India Smart Cities Project ...
September 2015
125 pages
Global Antibody Drug Conjugate Market & Pipeline Insight 2020
US$ 2,000.00
... Antibody Drug Conjugates Market Overview Mechanism of Antibody Drug Conjugates Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC Antibody Drug Conjugates ...
August 2015
350 pages
Histone Deacetylase (HDAC) Inhibitors Market & Pipeline Insight 2015
US$ 1,800.00
... Histone Deacetylase (HDAC) Inhibitors Mechanism of Histone Deacetylase (HDAC) Inhibitors Histone Deacetylase (HDAC) Inhibitors Market Dynamics Global Histone Deacetylase (HDAC) Inhibitor Market Outlook Histone Deacetylase (HDAC) Inhibitor Clinical Pipeline by Company, Indication & Phase Histone Deacetylase ...
August 2015
180 pages
Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015
US$ 3,000.00
... Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015” Report Highlight: Nomenclature & Classification of CD Antigens Mechanism of CD Antigen Cancer Therapeutics Cancer CD Antigen Therapy Market Overview Cancer CD Antigen Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer ...
August 2015
600 pages
Global Stem Cell Therapy Market Future Outlook
US$ 2,400.00
... Stem Cell Therapies Clinical Pipeline by Company, Indication & Phase Global Stem Cell Therapies in Clinical Pipeline: 114 Therapies Majority Stem Cell Therapies in Preclinical Phase: 38 Therapies Marketed Stem Cell Therapies Clinical Insight by Brand Name, Company & Indication Marketed Stem Cell Therapies ...
July 2015
300 pages
US Breast Cancer Therapy Market Opportunity Analysis
US$ 2,400.00
... Breast Cancer Incidence & Prevalence US Breast Cancer Therapy Market Overview US Breast Cancer Drug Clinical Pipeline by Company & Phase US Breast Cancer Drug Clinical Pipeline: 251 Drugs Majority Drugs in Phase-II Trials: 73 Drugs Marketed Breast Cancer Drugs in US: 32 Drugs Breast Cancer ...
July 2015
700 pages
US Blood Cancer Drug Market & Pipeline Analysis 2015
US$ 3,000.00
... & Prevalence Blood Cancer Drug Market Overview Blood Cancer Drug Market Dynamics Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline Insight Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline: 435 Drugs Majority Drugs in Phase-I Clinical Trials: 128 Drugs Marketed Leukemia, Lymphoma & Myeloma Drug Clinical ...
July 2015
1100 pages
Global Cancer Immunotherapy Market Outlook 2020
US$ 3,600.00
... Monoclonal Antibodies, Vaccines 'Global Cancer Immunotherapy Market Outlook 2020' Report Highlight: Introduction & Classification of Cancer Immunotherapy Global Cancer Immunotherapy Pipeline by Company, Indication & Phase Marketed Cancer Immunotherapies ...
June 2015
2600 pages
Cancer Immunomodulators Market & Pipeline Insight 2020
US$ 2,000.00
... Immunomodulators Cancer Immunomodulators Mechanism Cancer Immunomodulators Clinical Pipeline By Company, Indication & Phase Cancer Immunomodulators Clinical Pipeline: 747 Cancer Immunomodulators Drugs Majority Cancer Immunomodulators in Preclinical Phase: 300 Marketed Cancer Immunomodulators ...
June 2015
1000 pages
Global Cancer Biosimilars Market Opportunity Outlook
US$ 1,800.00
... Cancer Biosimilars Global Cancer Biosimilars Market Dynamics FDA & EMA Guidelines on Development & Marketing of Biosimilars Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase Cancer Biosimilars Clinical Pipeline: 100 Biosimilars Marketed Cancer Biosimilars Clinical Insight Marketed Cancer ...
June 2015
550 pages
US Cancer Vaccine Market Outlook 2020
US$ 2,000.00
... Cancer Vaccine Clinical Pipeline by Company, Indication & Phase US Cancer Vaccine Clinical Pipeline: 187 Vaccines Clinical Insight of Marketed Cancer Vaccines in US Marketed Cancer Vaccine in US: 5 Vaccines FDA Regulations for Clinical Trials of Cancer Vaccines Clinical Insight of Marketed Cancer Vaccines ...
May 2015
420 pages
Global Insulin Patch Market Opportunity Analysis
US$ 1,800.00
... insulin patch in global market in next few years. 'Global Insulin Patch Market Opportunity Analysis' Report Highlights: Introduction to Insulin Patch Mechanism Iontophoresis, Ultrasonic & Microneedle Insulin Patch Global Insulin Patch Market Analysis Global Insulin Patch ...
May 2015
75 pages
Global Multiple Myeloma Drug Market & Pipeline Insight 2015
US$ 1,800.00
... Multiple Myeloma Drug Market Analysis Global Multiple Myeloma Drug Clinical Insight by Company, Indication & Phase Marketed Multiple Myeloma Drugs Clinical Insight Mechanism of Multiple Myeloma Drug Global Multiple Myeloma Drug Clinical Pipeline: 164 Drugs Majority Multiple Myeloma Drugs ...
May 2015
415 pages
Global HIV Vaccine Market Future Outlook
US$ 2,000.00
... Introduction to HIV Vaccines Issues Related to the Development of HIV Vaccines Parameters for Successful Commercialization of HIV Vaccines Global HIV Vaccines Market Opportunity Analysis Global HIV Vaccine Clinical Pipeline by Company & Phase Global HIV Vaccine Clinical Pipeline: 100 Vaccines Majority Vaccine ...
May 2015
275 pages
Global Cell Therapy Market Outlook 2020
US$ 2,400.00
... of Stem Cells in Cell Therapy Global Cell Therapy Market Analysis Global Cell Therapy Clinical Pipeline by Country, Indication & Phase Marketed Cell Therapy Clinical Insight by Brand Name, Company & Indication Global Cell Therapy Clinical Pipeline: 262 Cell Therapies Marketed Cell Therapies: 13 Marketed Cell ...
May 2015
550 pages
Global Breast Cancer Monoclonal Antibodies Market Outlook 2020
US$ 1,800.00
... Cancer Monoclonal Antibodies Pipeline: 62 mAb Majority Breast Cancer Monoclonal Antibodies in Preclinical Phase: 17 mAb Marketed Breast Cancer Monoclonal Antibodies: 6 mAb Marketed Breast Cancer Monoclonal Antibodies Clinical Insight Bevacizumab (Avastin) Pertuzumab (Omnitarg, Perjeta) Trastuzumab (Herceptin ...
May 2015
190 pages
Global Diabetes Drug Market & Pipeline Insight 2015
US$ 2,400.00
... Global Diabetes Drug Market Overview Global Diabetic Drug Clinical Pipeline by Company & Phase Global Diabetic Drug Clinical Pipeline: 817 Drugs Majority in Preclinical Phase: 205 Drugs Type 2 Diabetes Mellitus Drugs in Pipeline: 380 Drugs Type 1 Diabetes Mellitus Drugs in Pipeline: 79 Drugs Diabetic ...
April 2015
1100 pages
Global Nanomedicine Market & Pipeline Insight 2015
US$ 2,400.00
... Global Nanomedicine Market & Pipeline Insight 2015” Report Highlights: Global Nanomedicine Market Outlook Global Nanomedicine Market Dynamics Global Nanomedicine Clinical Pipeline by Company, Indication & Phase Global Nanomedicine Clinical Pipeline: 144 Nanomedicines Marketed Nanomedicines: 13 Nanomedicines ...
April 2015
330 pages
Oncogene Inhibitors Therapy Market & Pipeline Insight 2015
US$ 2,400.00
... Oncogene Inhibitors Pipeline: 185 Drugs Majority Oncogene Inhibitors in Preclinical Phase: 105 Drugs Proto Oncogene Protein c met Inhibitors Pipeline: 42 Drugs Proto Oncogene Protein c-akt Inhibitors: 39 Drugs Marketed Oncogene Inhibitors: 22 Drugs Marketed Proto-Oncogene Protein c-bcl-2 Inhibitors: 8 Drugs ...
April 2015
500 pages
Tyrosine Kinase Inhibitors Market & Pipeline Insight 2015
US$ 2,400.00
... Tyrosine Kinase Therapeutics Global Tyrosine Kinase Inhibitors Pipeline by Company, Indication & Phase Global Tyrosine Kinase Inhibitors Pipeline: 557 Drugs Majority Drugs in Preclinical Phase: 239 Drugs Marketed Tyrosine Kinase Inhibitors: 58 Drugs Marketed Tyrosine Kinase Inhibitors ...
April 2015
1200 pages
Cancer Targeted Therapy Market & Clinical Insight 2015
US$ 3,300.00
... Cancer Targeted Therapy Market & Clinical Insight” Report Highlight: Introduction & Categorization of Cancer Targeted Therapies Mechanism of Cancer Targeted Tyrosine Kinase, Vaccines, Oncogenes Inhibitors, Monoclonal Antibodies Cancer Targeted Therapy ...
April 2015
2900 pages
Cancer Growth Inhibitors Market & Clinical Pipeline Analysis
US$ 2,400.00
... Cancer Growth Inhibitors Cancer Growth Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer Growth Inhibitors Clinical Pipeline: 629 Drugs Markets Cancer Growth Inhibitors: 48 Drugs Tyrosine Kinase Dominates Cancer Growth Inhibitors Pipeline: 394 Drugs HDAC Inhibitors Clinical Pipeline: 65 Drugs ...
April 2015
1000 pages
Global Interferon Market & Pipeline Analysis 2015
US$ 1,800.00
... Global Interferon Market & Pipeline Analysis 2015” Report Highlights: Introduction & Classification of Interferons Interferon Clinical Pipeline Country, Indication & Phase Interferon Clinical Pipeline: 79 Drugs Majority Interferon Drugs in Preclinical Phase: 29 Drugs Marketed Interferon Drugs: 37 Drugs ...
April 2015
230 pages
Global Peptide Hormone Market & Pipeline Analysis
US$ 1,500.00
... Global Peptide Hormone Market Overview Peptide Hormones Clinical Pipeline by Company, Indication & Phase Marketed Peptide Hormones by Company & Indication Peptide Hormones Clinical Pipeline: 47 Drugs Majority Peptide Hormone in Phase-II Trials: 15 Drugs Marketed Peptide Hormones: 24 Drugs Global Peptide ...
April 2015
180 pages
Global Lung Cancer Vaccine Market & Pipeline Insight 2015
US$ 1,200.00
... Lung Cancer Vaccine Global Lung Cancer Vaccine Market Analysis Global Lung Cancer Vaccine Pipeline by Company & Phase Global Lung Cancer Vaccine Pipeline: 29 Vaccines Majority Lung Cancer Vaccines in Phase-II: 8 Vaccines Marketed Lung Cancer Vaccines: 3 ( BV NSCLC 001, Mycidac-C & Vaxira) Personalized Cancer ...
February 2015
120 pages
Global Skin Cancer Vaccine Market & Pipeline Insight 2015
US$ 1,500.00
... Skin Cancer Vaccine Global Skin Cancer Vaccine Market Analysis Global Skin Cancer Vaccine Pipeline by Company & Phase Global Skin Cancer Vaccine Pipeline: 47 Vaccines Majority Skin Cancer Vaccines in Phase-I: 12 Vaccines Marketed Skin Cancer Vaccines ...
February 2015
179 pages
Global Transdermal Patch Market & Pipeline Insight 2015
US$ 2,400.00
... Transdermal Patch Drug Delivery Global Transdermal Patch Market Outlook Transdermal Patch Clinical Pipeline by Company, Indication & Phase Transdermal Patches in Clinical Pipeline: 96 Marketed Transdermal Patches: 45 Global Transdermal Patch Market ...
February 2015
300 pages
Cancer Nanomedicine Market & Pipeline Insight 2015
US$ 2,000.00
... cancer therapy can be achieved. “Cancer Nanomedicine Market & Pipeline Insight 2015” Report Highlight Nanomedicine for Cancer Therapies Cancer Nanoparticles Drug Delivery Systems Classification Mechanism of Cancer Nanomedicine Therapy Cancer Nanomedicine Clinical Pipeline Overview Cancer Nanomedicine ...
February 2015
220 pages
Dendritic Cell Cancer Vaccine Market & Clinical Insight
US$ 1,800.00
... Dendritic Cell Cancer Vaccines Dendritic Cell Vaccine Market Overview Market Dynamics (Drivers, Challenges & Future Prospects) Clinical Pipeline Insight by Phase, Indication & Company Dendritic Cell Cancer Vaccine in Clinical Pipeline: 52 Majority of Dendritic Cell Cancer Vaccine ...
January 2015
190 pages
Global Non Small Cell Lung Cancer Market & Pipeline Insight
US$ 2,400.00
... Non Small Cell Lung Cancer Market & Pipeline Insight” Report Highlights: NSCLC Therapy Market Overview Mechanism of NSCLC Therapeutics NSCLC Therapy Market Dynamics: Drivers, Challenges & Future Prospects) NSCLC Drug Pipeline ...
January 2015
750 pages
Global Peptide Vaccine Market & Pipeline Insight
US$ 1,800.00
... Global Peptide Vaccine Market & Pipeline Insight” Report Highlights: Introduction & Mechanism of Peptide Vaccine Peptide Vaccine Market Overview Peptide Vaccine Market Dynamics (Drivers, Challenges & Future Outlook) Peptide Vaccine Pipeline by Phase, Indication, Company & Country Peptide Vaccine Pipeline ...
January 2015
200 pages
US Proton Therapy Market Opportunity Analysis
US$ 1,500.00
... Proton Therapy Market Opportunity Analysis” Report Highlight: US Proton Therapy Market Overview Targeted Patient Base & Economic Capacity Analysis Proton Therapy Cost Analysis Proton Therapy Reimbursement Policy Proton Therapy Center Infrastructure Analysis US Proton Therapy Market ...
December 2014
87 pages
US Shale Gas Industry Analysis
US$ 1,800.00
... production costs. “US Shale Gas Industry Analysis” Report Highlight: US Shale Gas Industry Overview Shale Gas Exploration, Technical and Technology Aspects US Shale Gas Reserve Analysis: Technical & Recoverable Reserves Investments in Shale Gas Exploration & Production US Shale Gas ...
November 2014
96 pages
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight
US$ 2,400.00
... Non Hodgkin Lymphoma therapeutics. “Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight” Report Highlight: Global Non Hodgkin Lymphoma Market Overview Mechanism of Non Hodgkin Lymphoma Therapeutics Global Non Hodgkin Lymphoma Pipeline by Type, Phase & Company Global Non Hodgkin Lymphoma Pipeline ...
November 2014
573 pages
Global Cancer Monoclonal Antibodies Market & Pipeline Insight
US$ 2,400.00
... Cancer Monoclonal Antibodies Pipeline by Phase, Indication, Company & Country Cancer Monoclonal Antibodies in Pipeline: 605 Majority Cancer Monoclonal Antibodies Preclinical Phase: 258 Marketed Cancer Monoclonal Antibodies: 34 Cancer Monoclonal Antibodies ...
October 2014
1400 pages
Europe Biosimilars Market & Pipeline Insight
US$ 2,400.00
... Europe Biosimilars Market & Pipeline Insight” Report Highlight: Biosimilars Market Overview & Trend Analysis by Country Biosimilars Introduction Timeline in Europe Biosimilars Development & Market Authorization Guidelines Biosimilars Clinical Pipeline by Phase, Indication, Company & Country Marketed ...
October 2014
360 pages
Global Cancer Kinase Inhibitors Market & Pipeline Insight
US$ 2,400.00
... Global Cancer Kinase Inhibitors Market & Pipeline Insight” Report Highlight: Classification & Mechanism of Kinase Inhibitors Cancer Kinase Inhibitors Therapy Market Overview Cancer Kinase Inhibitors Therapy Pipeline by Phase, Indication, Company & Country Marketed Cancer Kinase Inhibitors Therapy ...
October 2014
1500 pages
Global Gene Therapy Market & Pipeline Insight
US$ 2,400.00
... Gene Therapy to Cancer Treatment Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook FDA & AMA Guidelines for Gene Therapy Gene Therapy Pipeline by Phase, Indications, Country & Company Gene Therapy Pipeline: 246 Drugs Marketed Gene Therapy: 2 (Gendicine & Rexin-G) Cancer Gene Therapy Pipeline ...
October 2014
949 pages
Ebola Virus Vaccine Market & Pipeline Insight
US$ 1,500.00
... Ebola Virus Vaccine Market & Pipeline Insight” Report Highlight: Ebola Virus Infection Market Overview Ebola Vaccine Clinical Trial Insight by Phase, Company & Country Ebola Vaccine in Clinical Trials: 26 Vaccine Majority Ebola Vaccine in Preclinical Phase: 15 Vaccines Ebola Vaccines ...
October 2014
80 pages
